Dropout from the pentavalent vaccine series among children aged 12-23 months in the Central African Republic: prevalence, associated factors, and caregiver-reported barriers

By afschroeder • May 16, 2026

Ishoso DK, Fandema E, Hoff NA, Nkamba DM, Merritt S, Halbrook M, de Dieu Longo J, Mafuta Musalu E, Kasonga Ngindu JB, Bangelesa F, Stahley K, Fangbilette JLK, Djekou C, Matkoss FE, Bobo ES, Zanga-Goumet HE, Patrice FM, El Mourid A, Somse P, Manirakiza A, Rimoin AW, Kaba DK. Dropout from the pentavalent vaccine series among children aged 12-23 months in the Central African Republic: prevalence, associated factors, and caregiver-reported barriers. Vaccine. 2026 May 15;85:128700. doi: 10.1016/j.vaccine.2026.128700. Epub ahead of print. PMID: 42140089.

Tags: Caregiver barriers, Central African Republic, Child health, Immunization coverage, Infectious Diseases, Pentavalent vaccine, Publications, Vaccination dropout

β-Glucan chitosan particle provides cross-protection against multi-drug-resistant Candida auris

Singh S, Barbarino A, Youssef EG, Das Gupta K, Nabeela S, Gebremariam T, Alkhazraji S, Uppuluri P, Ostroff G, Ibrahim AS. β-Glucan chitosan particle provides[...]

High usage of telephone telemedicine among people living with HIV at two federally qualified health centers in Los Angeles

Hoffman R, Walker D, Butler D, Tseng CH, Shoptaw S, Currier JS, Gladstein J, Moucheraud C. High usage of telephone telemedicine among people living with[...]

Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges. Reply

Rana AI, Castillo-Mancilla J, Landovitz RJ. Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges. Reply. N Engl J Med. 2026 May 14;394(19):1963-1964. doi:[...]